图片、数据来源：沪深交易所等，截至2025.11.26。 成份股方面，生猪养殖、种子、畜禽饲料、动保等板块部分个股涨幅居前。截至发稿，罗牛山大涨超5%，神农种业涨超4%，海南橡胶、美农 生物、金新农等多股跟涨超2%。 江海证券指出，在"反内卷"的政策调控和亏损减产的双重驱动下，行业产能有望迎来加速去化期，或可左侧布局生猪养殖板块。中长期看，在 行业高质量发展的背景下，龙头养殖企业成本持续下降，周期头均盈利中枢或将提升，叠加政策控制资本开支减少，企业持续稳定现金流增加 分红预期，或可考虑左侧布局生猪养殖企业。 从估值方面来看，当前农牧渔板块或迎来较好配置时机。数据显示，截至昨日（11月25日）收盘，农牧渔ETF（159275）标的指数中证全指农 牧渔指数市净率为2.56倍，位于近10年来28.91%分位点的低位，中长期配置性价比凸显。 展望后市，中邮证券指出，当前距离产能调减目标设定的时间期限越来越近，政策执行力度、养殖企业压力等都将有所加大；同时行业全面亏 损继续，且供给压力短期难以缓解，产能被动去化将有所增加；另外秋冬季节疾病扰动加剧。政策、行业周期性及季节性影响等多重因素影响 下，预计近期生猪产能去化仍是 ...

今年以来兄弟科技已经9次登上龙虎榜，最近一次登上龙虎榜为9月25日，当日龙虎榜净买入-5801.97万 元；买入总计1.27亿元 ，占总成交额比7.06%；卖出总计1.85亿元 ，占总成交额比10.28%。 11月25日，兄弟科技盘中上涨2.01%，截至10:06，报6.59元/股，成交3937.49万元，换手率0.86%，总市 值75.31亿元。 资金流向方面，主力资金净流入115.89万元，大单买入483.60万元，占比12.28%，卖出367.71万元，占 比9.34%。 兄弟科技今年以来股价涨55.06%，近5个交易日跌5.72%，近20日跌7.57%，近60日跌2.66%。 责任编辑：小浪快报 分红方面，兄弟科技A股上市后累计派现3.90亿元。近三年，累计派现1.06亿元。 机构持仓方面，截止2025年9月30日，兄弟科技十大流通股东中，国泰中证畜牧养殖ETF（159865）位 居第三大流通股东，持股1413.11万股，相比上期增加504.55万股。招商中证畜牧养殖ETF（516670）位 居第九大流通股东，持股204.98万股，为新进股东。 资料显示，兄弟科技股份有限公司位于浙江省海宁市海洲街道学 ...

来源：新浪证券-红岸工作室 11月24日，百龙创园涨3.74%，成交额9154.56万元，换手率1.09%，总市值84.97亿元。 异动分析 资金分析 今日主力净流入-359.05万，占比0.04%，行业排名124/181，连续3日被主力资金减仓；所属行业主力净 流入-10.54亿，连续3日被主力资金减仓。 区间今日近3日近5日近10日近20日主力净流入-359.05万-1093.77万-2039.85万-2870.77万-870.32万 主力没有控盘，筹码分布非常分散，主力成交额3108.10万，占总成交额的9.71%。 2、2024年半年报，公司持有山东禹城农村商业银行股份有限公司 5.14%股份。 3、根据2024年年报，公司海外营收占比为60.62%，受益于人民币贬值。 4、专精特新"小巨人"企业是全国中小企业评定工作中最高等级、最具权威的荣誉称号，是指专注于细 分市场、创新能力强、市场占有率高、掌握关键核心技术、质量效益优的排头兵企业，对于提升中小企 业自身的竞争力，以及提升产业链、供应链稳定性和竞争力具有重大意义。公司已入选工信部专精特新 小巨人企业名单。 (免责声明：分析内容来源于互联网，不构成 ...

责任编辑：小浪快报 截至9月30日，梅花生物股东户数6.67万，较上期增加13.10%；人均流通股42058股，较上期减少 13.09%。2025年1月-9月，梅花生物实现营业收入182.15亿元，同比减少2.49%；归母净利润30.25亿元， 同比增长51.61%。 分红方面，梅花生物A股上市后累计派现120.47亿元。近三年，累计派现40.75亿元。 机构持仓方面，截止2025年9月30日，梅花生物十大流通股东中，香港中央结算有限公司位居第二大流 通股东，持股9892.29万股，相比上期增加1833.66万股。国泰中证畜牧养殖ETF（159865）位居第七大 流通股东，持股4459.03万股，为新进股东。南方标普中国A股大盘红利低波50ETF联接A（008163）位 居第九大流通股东，持股3204.72万股，为新进股东。兴全合润混合A（163406）、兴全合宜混合A （163417）退出十大流通股东之列。 11月21日，梅花生物盘中下跌2.07%，截至13:56，报10.40元/股，成交3.07亿元，换手率1.04%，总市值 291.64亿元。 资金流向方面，主力资金净流出873.22万元，特大单买入16 ...

11月19日，醋化股份盘中下跌2.15%，截至10:46，报12.28元/股，成交1447.41万元，换手率0.57%，总 市值25.11亿元。 醋化股份今年以来股价涨32.47%，近5个交易日跌2.54%，近20日涨0.00%，近60日跌5.10%。 资料显示，南通醋酸化工股份有限公司位于江苏省南通经济技术开发区江山路968号，成立日期，上市 日期2015年5月18日，公司主营业务涉及从事以醋酸衍生物、吡啶衍生物为主体的高端专用精细化学品 的研发、生产和销售。主营业务收入构成为：食品饲料添加剂28.53%，医药农药中间体20.29%，农化 类17.09%，其他商品12.51%，颜(染)料中间体11.97%，其他有机化合物7.19%，其他(补充)2.41%。 醋化股份所属申万行业为：基础化工-化学制品-食品及饲料添加剂。所属概念板块包括：微盘股、小 盘、代糖概念等。 截至9月30日，醋化股份股东户数1.16万，较上期减少13.79%；人均流通股17697股，较上期增加 15.99%。2025年1月-9月，醋化股份实现营业收入19.91亿元，同比减少9.44%；归母净利润-2423.02万 元，同比增长74.1 ...

11月18日，金丹科技盘中下跌2.00%，截至14:26，报18.60元/股，成交8187.03万元，换手率2.75%，总 市值42.27亿元。 金丹科技所属申万行业为：基础化工-化学制品-食品及饲料添加剂。所属概念板块包括：可降解、小 盘、土地流转、新材料等。 截至9月30日，金丹科技股东户数2.02万，较上期减少9.31%；人均流通股7830股，较上期增加16.34%。 2025年1月-9月，金丹科技实现营业收入12.04亿元，同比增长8.41%；归母净利润1.32亿元，同比增长 30.06%。 分红方面，金丹科技A股上市后累计派现8401.33万元。近三年，累计派现4788.24万元。 责任编辑：小浪快报 资金流向方面，主力资金净流出862.82万元，特大单买入227.92万元，占比2.78%，卖出220.70万元，占 比2.70%；大单买入974.17万元，占比11.90%，卖出1844.21万元，占比22.53%。 金丹科技今年以来股价跌0.75%，近5个交易日跌2.46%，近20日涨4.03%，近60日跌2.36%。 资料显示，河南金丹乳酸科技股份有限公司位于河南省周口市郸城县金丹大道08号，成立 ...

Core Viewpoint - The company, Shandong Bailong Chuangyuan Biotechnology Co., Ltd., is experiencing a decline in stock price while benefiting from its unique product offerings and strategic investments, particularly in the context of the depreciating RMB and its recognition as a "specialized, refined, distinctive, and innovative" enterprise. Group 1: Company Overview - The company specializes in the research, production, and sales of prebiotics, dietary fibers, and healthy sweeteners, with a revenue composition of 54.15% from dietary fibers, 28.00% from prebiotics, 13.57% from healthy sweeteners, and 3.91% from other products [8] - As of October 31, the company had 13,400 shareholders, an increase of 3.75% from the previous period, with an average of 31,274 circulating shares per shareholder, a decrease of 3.62% [8] - The company reported a revenue of 969 million yuan for the period from January to September 2025, representing an 18.10% year-on-year growth, and a net profit of 265 million yuan, up 44.93% year-on-year [8] Group 2: Market Position and Financials - The company holds a 5.14% stake in Shandong Yucheng Rural Commercial Bank, which may provide additional financial stability and growth opportunities [3] - The overseas revenue accounted for 60.62% of total revenue, benefiting from the depreciation of the RMB [4] - The company has distributed a total of 183 million yuan in dividends since its A-share listing, with 172 million yuan distributed over the past three years [9] Group 3: Investment Highlights - The company produces allulose, a rare monosaccharide that serves as a low-calorie sugar substitute, making it ideal for individuals with obesity and diabetes [2] - The company has been recognized as a "specialized, refined, distinctive, and innovative" enterprise, which enhances its competitiveness and stability within the industry [4] - The stock has seen a recent decline of 2.07%, with a trading volume of 96.14 million yuan and a market capitalization of 8.753 billion yuan [1]

Core Viewpoint - The stock of Jia Bi You has shown a mixed performance in recent trading sessions, with a year-to-date increase of 29% but a decline over the past 20 and 60 days, indicating volatility in investor sentiment [1][2]. Group 1: Stock Performance - On November 10, Jia Bi You's stock rose by 2.02%, reaching a price of 24.29 yuan per share, with a trading volume of 34.99 million yuan and a turnover rate of 0.87% [1]. - Year-to-date, Jia Bi You's stock has increased by 29.00%, while it has seen a decline of 7.04% over the past 20 days and 12.94% over the past 60 days [1]. - The company has appeared on the "龙虎榜" (a stock trading list) once this year, with the most recent appearance on March 14, where it recorded a net buy of 18.50 million yuan [1]. Group 2: Company Overview - Jia Bi You Biotechnology (Wuhan) Co., Ltd. was established on September 22, 2004, and went public on December 19, 2019. The company specializes in the research, production, and sales of polyunsaturated fatty acids such as ARA and DHA, as well as natural β-carotene [2]. - The main revenue sources for Jia Bi You are ARA products (76.16%), DHA products (21.24%), and other supplements (2.60%) [2]. - The company operates within the basic chemical industry, specifically in food and feed additives, and is associated with concepts such as pet economy and synthetic biology [2]. Group 3: Financial Performance - For the period from January to September 2025, Jia Bi You achieved a revenue of 428 million yuan, reflecting a year-on-year growth of 10.56%, while the net profit attributable to the parent company was 129 million yuan, marking a significant increase of 54.18% [2]. - Since its A-share listing, Jia Bi You has distributed a total of 243 million yuan in dividends, with 103 million yuan distributed over the past three years [3]. - As of September 30, 2025, the number of shareholders increased to 8,362, with an average of 20,127 circulating shares per person, a slight decrease of 1.00% from the previous period [2].

来源：新浪证券-红岸工作室 11月7日，百龙创园涨1.00%，成交额9553.56万元，换手率1.08%，总市值88.83亿元。 (免责声明：分析内容来源于互联网，不构成投资建议，请投资者根据不同行情独立判断) 资金分析 今日主力净流入461.51万，占比0.05%，行业排名53/181，连续2日被主力资金增仓；所属行业主力净流 入33.32亿，连续3日被主力资金增仓。 异动分析 区间今日近3日近5日近10日近20日主力净流入461.51万363.63万-244.30万1236.16万565.01万 代糖概念+参股银行+人民币贬值受益+专精特新 1、公司生产的健康甜味剂产品主要为阿洛酮糖，阿洛酮糖是在自然界中天然存在但含量极少的一种稀 有单糖，其甜味及口感与蔗糖相当类似或接近，但其热量却远低于蔗糖，对于肥胖以及糖尿病患者是一 种理想的蔗糖代替物。 2、2024年半年报，公司持有山东禹城农村商业银行股份有限公司 5.14%股份。 3、根据2024年年报，公司海外营收占比为60.62%，受益于人民币贬值。 4、专精特新"小巨人"企业是全国中小企业评定工作中最高等级、最具权威的荣誉称号，是指专注于细 分市场、创新能 ...

Core Viewpoint - Xinghuo Technology's stock has shown a mixed performance in recent trading, with a year-to-date increase of 20.36% but a decline over the last 20 and 60 days, indicating volatility in its market position [1]. Financial Performance - For the period from January to September 2025, Xinghuo Technology reported a revenue of 12.077 billion yuan, a year-on-year decrease of 5.57%, while the net profit attributable to shareholders increased by 49.90% to 1.015 billion yuan [2]. - Cumulatively, the company has distributed 1.57 billion yuan in dividends since its A-share listing, with 1.263 billion yuan distributed over the past three years [3]. Shareholder and Market Activity - As of September 30, 2025, the number of shareholders increased by 2.44% to 45,900, with an average of 27,354 circulating shares per person, reflecting growing investor interest [2]. - Major shareholders include Hong Kong Central Clearing Limited, which increased its holdings by 10.58 million shares, and Guotai CSI Livestock Breeding ETF, which added 6.73 million shares [3]. Business Overview - Xinghuo Technology, established in April 1992 and listed in August 1994, specializes in the research, production, and sales of food additives, feed additives, chemical raw materials, and pharmaceutical intermediates [1]. - The company's revenue composition includes feed additives (67.69%), food additives (24.50%), and other segments such as organic fertilizers and pharmaceutical intermediates [1]. Market Position - Xinghuo Technology is classified under the basic chemical industry, specifically in the chemical products sector focusing on food and feed additives, and is associated with various concept sectors including seasoning, synthetic biology, and biomedicine [1].